VA-Based Survey of Osteoporosis Management in Spinal Cord Injury
Objective
Although osteoporosis is common following spinal cord injury (SCI), no guidelines exist for its treatment, diagnosis, or prevention. The authors hypothesized that wide variations in diagnosis and treatment practices result from the absence of guidelines. This study sought to characterize the diagnosis and management practices within the VA health care system for osteoporosis following SCI.
Design
Online survey regarding osteoporosis management in SCI composed of 27 questions designed to gather information on responder demographics, osteoporosis diagnostics, and treatment options.
Setting
VA health care system.
Participants
VHA National SCI Staff Physicians and VHA National SCI Nurses (total n = 450) were sent an email with an invitation to participate.
Intervention
Not applicable.
Main Outcome Measures
Practice patterns were assessed, including factors associated with ordering a clinical workup and prescribing osteoporosis treatment.
Results
The response rate was 28%. Ninety-two prescribing practitioners (physicians, nurse practitioners, and physician assistants) were included in the analysis. Of these respondents, 50 (54%) prescribe medications for SCI-induced bone loss; 39 (42%) prescribe bisphosphonates and 46 (50%) prescribe vitamin D. There were 54 (59%) respondents who routinely order diagnostic tests, including dual energy x-ray absorptiometry scans in 50 (54%). Variations in practice were not explained by age, gender, or years practicing SCI medicine. Many respondents (23%) reported barriers to osteoporosis testing including lack of scanning protocols, cost, wheelchair inaccessibility of scanning facilities, and lack of effective treatment guidelines once osteoporosis is diagnosed.
Conclusions
Despite an absence of screening and treatment guidelines, more than half of all respondents are actively diagnosing and treating osteoporosis with bisphosphonates within the VA health care setting. These data suggest that evidence-based practice guidelines are necessary to reduce practice variations and improve clinical care for this population.
To access this article, please choose from the options below
- † Disclosure: nothing to disclose
- ‡ Disclosure: 7A, co-investigation on Merck Frosst-funded study
- § Disclosure: nothing to disclose
- ¶ Disclosure: nothing to disclose
- ∥ Disclosure: nothing to disclose
- # Disclosure: nothing to disclose
- ⁎⁎ Disclosure: nothing to disclose
- †† Disclosure: nothing to disclose
- ‡‡ Disclosure: nothing to disclose
Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org
The project reported/outlined here was supported by the Office of Research and Development, Health Services R&D Service, Quality Enhancement Research Initiative RRP-07-312, NIH/NICHD RO1 HD42141 (Dr. Garshick), R21HD057030 (Morse), and K12 HD001097-08 (Dr. Morse).
The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.
PII: S1934-1482(08)00019-1
doi:10.1016/j.pmrj.2008.10.008
© 2009 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.
